advisorsecurities master

CNTXContext Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
13587
Ticker
CNTX
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-10-20
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CNTX

Detail

Enriched 2026-08-14 20:47

Market cap
$43,174,025.27
Shares outstanding (class)
91,879,177
Shares outstanding (weighted)
91,879,177
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
15
Location
PHILADELPHIA, PA
Description

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data